• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vigil Neuroscience, Inc. - Common Stock (NQ:VIGL)

8.050 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.050
Bid (Size) 8.060 (1)
Ask (Size) 8.080 (29)
Prev. Close 8.050
Today's Range 8.050 - 8.050
52wk Range 1.312 - 8.100
Shares Outstanding 35,685,129
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
As the curtains draw on 2025, the biotechnology sector has emerged as the undisputed champion of the equity markets, staging a dramatic year-end rally that has caught even the most optimistic analysts... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Loss-Making Russell 2000 Stocks Drive Surprise Rally, Says Liz Ann Sonders ↗
October 10, 2025
Liz Ann Sonders, the Chief Investment Strategist at Charles Schwab & Co. (NYSE: SCHW) highlighted certain unusual divergences in the small cap markets. 
Via Benzinga

Performance

YTD
+354.8%
+354.8%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+1.0%
+1.0%
1 Year
+426.1%
+426.1%

More News

Read More
News headline image
Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel ↗
July 25, 2025
Via Benzinga
News headline image
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL
July 14, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders
July 03, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders
June 13, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)
June 13, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)
June 09, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Flowserve Corporation (NYSE – FLS), Streamline Health Solutions, Inc. (Nasdaq – STRM), Sitio Royalties Corp. (NYSE – STR), Vigil Neuroscience, Inc. (Nasdaq – VIGL)
June 04, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders
June 04, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
June 04, 2025
From Vigil Neuroscience, Inc.
Via GlobeNewswire
News headline image
Peraso Inc. (NASDAQ: PRSO) Aligned with BEAD Act’s $42.45B Broadband Mission: Driving Scalable Wireless Innovation
May 27, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Synergy CHC Corp. (NASDAQ: SNYR) Eyes Roth Capital’s Target Amid Profit Streak, Global Expansion & Sector Momentum
May 27, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
May 27, 2025
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders
May 24, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Which stocks have an unusual volume on Friday? ↗
May 23, 2025
Via Chartmill
News headline image
US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert ↗
May 23, 2025
Via Benzinga
News headline image
Nasdaq Gains Over 50 Points Following Positive Economic Reports: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone ↗
May 23, 2025
Via Benzinga
News headline image
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL
May 22, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Navitas (NASDAQ: NVTS) Surges on NVIDIA Deal – SNYR, VIGL, XAGE Lead $2 Stock Watch Now, More Inside
May 22, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
May 22, 2025
Via Benzinga
News headline image
Dow Moves Higher; US Initial Jobless Claims Fall ↗
May 22, 2025
Via Benzinga
Topics Stocks
News headline image
Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views ↗
May 22, 2025
Via Benzinga
News headline image
Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying ↗
May 22, 2025
Via Investor's Business Daily
News headline image
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday ↗
May 22, 2025
Via Benzinga

Frequently Asked Questions

Is Vigil Neuroscience, Inc. - Common Stock publicly traded?
Yes, Vigil Neuroscience, Inc. - Common Stock is publicly traded.
What exchange does Vigil Neuroscience, Inc. - Common Stock trade on?
Vigil Neuroscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vigil Neuroscience, Inc. - Common Stock?
The ticker symbol for Vigil Neuroscience, Inc. - Common Stock is VIGL on the Nasdaq Stock Market
What is the current price of Vigil Neuroscience, Inc. - Common Stock?
The current price of Vigil Neuroscience, Inc. - Common Stock is 8.050
When was Vigil Neuroscience, Inc. - Common Stock last traded?
The last trade of Vigil Neuroscience, Inc. - Common Stock was at 08/04/25 04:00 PM ET
What is the market capitalization of Vigil Neuroscience, Inc. - Common Stock?
The market capitalization of Vigil Neuroscience, Inc. - Common Stock is 287.27M
How many shares of Vigil Neuroscience, Inc. - Common Stock are outstanding?
Vigil Neuroscience, Inc. - Common Stock has 287M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap